UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1943-01-01
- Employees
- 8.1K
- Market Cap
- -
Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome
- First Posted Date
- 2012-07-31
- Last Posted Date
- 2023-03-14
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT01654276
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Pharmacologic MRI in Cocaine Addiction
- First Posted Date
- 2012-07-30
- Last Posted Date
- 2019-09-09
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 12
- Registration Number
- NCT01652378
- Locations
- 🇺🇸
UT Southwestern Medical Center at Dallas, Divison on Addictions, Dallas, Texas, United States
A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma
Phase 1
Completed
- Conditions
- Rectal Adenocarcinoma
- Interventions
- First Posted Date
- 2012-07-06
- Last Posted Date
- 2020-08-20
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT01634685
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders
Recruiting
- Conditions
- Transverse MyelitisNeuromyelitis Optica Spectrum DisorderNeuromyelitis OpticaOptic Neuritis
- First Posted Date
- 2012-06-19
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 150
- Registration Number
- NCT01623076
- Locations
- 🇺🇸
The University of Texas Southwestern Medical Center, Dallas, Texas, United States
Effects of Bupivacaine Induced Motor Blockade During the Second Stage of Labor
Phase 4
Completed
- Conditions
- Pregnancy
- Interventions
- Drug: Epidural Bupivacaine plus fentanyl
- First Posted Date
- 2012-06-18
- Last Posted Date
- 2020-08-24
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 481
- Registration Number
- NCT01621230
- Locations
- 🇺🇸
Parkland Health and Hospital System, Dallas, Texas, United States
Vitamin C for Severe Thermal Injuries
Phase 2
Withdrawn
- Conditions
- Severe Thermal Injury, Greater Than 20% TBSA
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-04-30
- Last Posted Date
- 2019-03-06
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Registration Number
- NCT01587261
- Locations
- 🇺🇸
Parkland Memorial Hospital, Dallas, Texas, United States
Electronic-Measurement Based Care for Major Depressive Disorder
Not Applicable
Withdrawn
- Conditions
- Major Depressive Disorder
- Interventions
- Behavioral: e-MBC
- First Posted Date
- 2012-04-24
- Last Posted Date
- 2019-02-05
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Registration Number
- NCT01583998
- Locations
- 🇺🇸
The University of Texas Southwestern Medical Center, Dallas, Texas, United States
Impact of Body Weight on Pharmacokinetic Analysis of Doxorubicin + Cyclophosphamide in Breast Cancer
Withdrawn
- Conditions
- Breast Cancer
- First Posted Date
- 2012-03-02
- Last Posted Date
- 2018-06-06
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Registration Number
- NCT01542203
- Locations
- 🇺🇸
UTSouthwestern Medical Center, Dallas, Texas, United States
Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation
Phase 4
Completed
- Conditions
- Asthma
- Interventions
- Drug: Nebulized magnesium sulfate
- First Posted Date
- 2012-01-24
- Last Posted Date
- 2019-02-21
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT01515995
- Locations
- 🇺🇸
Children's Medical Center Dallas, Dallas, Texas, United States
Clinical Trial of ARQ 761 in Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Solid Tumors
- Interventions
- Drug: ARQ 761 Weekly AdministrationDrug: Bi-Weekly Administration of ARQ 761Drug: Two Consecutive Weeks Administration of ARQ 761 with one week of rest
- First Posted Date
- 2012-01-02
- Last Posted Date
- 2020-03-17
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 91
- Registration Number
- NCT01502800
- Locations
- 🇺🇸
UT Southwestern Medical Center - Simmons Cancer Center, Dallas, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath